We report the experimental observation of Ising superconductivity in three-dimensional NbSe 2 stacked with single-layer MoS 2 . The angular dependence of the upper critical magnetic field and the temperature dependence of the upper parallel critical field confirm the appearance of two-dimensional Ising superconductivity in threedimensional NbSe 2 with a single-layer MoS 2 overlay. We show that the superconducting phase has strong Ising spin-orbit correlations which make the holes spin nondegenerate. Our observation of Ising superconductivity in heterostructures of few-layer NbSe 2 of thickness ∼15 nm with single-layer MoS 2 raises the interesting prospect of observing topological chiral superconductors with nontrivial Chern numbers in a momentum-space spin-split fermionic system.
A study of Berezinskii–Kosterlitz–Thouless transitions in clean, layered two-dimensional superconductors promises to provide insight into a host of novel phenomena like re-entrant vortex-dynamics, underlying unconventional metallic phases, and topological superconductivity. In this Letter, we report the study of charge carrier dynamics in a novel two-dimensional superconducting van der Waals heterostructure comprising of monolayer MoS2 and few-layer NbSe2 ([Formula: see text] nm). Using low-frequency conductance fluctuation spectroscopy, we show that the superconducting transition in the system is percolative. We present a phenomenological picture of different phases across the transition correlating with the evaluated noise. The analysis of the higher order statistics of fluctuation reveals non-Gaussian components around the transition indicative of long-range correlation in the system.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.